AIM IMMUNOTECH INC. Increase Decrease In Operating Lease Liability
AIM IMMUNOTECH INC. (AIM) reported Increase Decrease In Operating Lease Liability of -$120.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-07
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$50.00K.
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$70.00K.
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$134.00K.
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$56.00K.
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for fiscal 2025 was -$268.00K.
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for fiscal 2024 was -$309.00K.
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for fiscal 2023 was -$274.00K, a 139.83% decline from fiscal 2022.
- AIM IMMUNOTECH INC. increase decrease in operating lease liability for fiscal 2022 was $688.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$120.00K 10-Q · filed 2026-08-07 | -$254.00K derived: sum of 3 quarters · filed 2026-08-07 | -$310.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$70.00K 10-Q · filed 2026-05-15 | -$204.00K derived: sum of 2 quarters · filed 2026-05-15 | -$260.00K derived: sum of 3 quarters · filed 2026-05-15 | -$276.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$190.00K derived: sum of 2 quarters · filed 2026-03-27 | -$206.00K derived: sum of 3 quarters · filed 2026-08-07 | -$268.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$72.00K derived: sum of 2 quarters · filed 2026-08-07 | -$134.00K 10-Q · filed 2025-11-17 | -$212.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$78.00K 10-Q · filed 2026-08-07 | -$156.00K derived: sum of 3 quarters · filed 2026-08-07 | -$238.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$62.00K 10-Q · filed 2026-05-15 | -$140.00K derived: sum of 2 quarters · filed 2026-05-15 | -$222.00K derived: sum of 3 quarters · filed 2026-05-15 | -$431.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$160.00K derived: sum of 2 quarters · filed 2026-03-27 | -$369.00K derived: sum of 3 quarters · filed 2026-03-27 | -$309.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$291.00K derived: sum of 2 quarters · filed 2025-11-17 | -$231.00K 10-Q · filed 2025-11-17 | -$369.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$149.00K 10-Q · filed 2025-08-14 | -$287.00K derived: sum of 3 quarters · filed 2025-08-14 | -$389.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $60.00K 10-Q · filed 2025-05-15 | -$78.00K derived: sum of 2 quarters · filed 2025-05-15 | -$180.00K derived: sum of 3 quarters · filed 2025-05-15 | -$191.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$240.00K derived: sum of 2 quarters · filed 2025-03-27 | -$251.00K derived: sum of 3 quarters · filed 2025-03-27 | -$274.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$113.00K derived: sum of 2 quarters · filed 2024-11-14 | -$136.00K 10-Q · filed 2024-11-14 | -$165.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$34.00K 10-Q · filed 2024-08-14 | -$63.00K derived: sum of 3 quarters · filed 2024-08-14 | -$86.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$23.00K 10-Q · filed 2024-05-15 | -$52.00K derived: sum of 2 quarters · filed 2024-05-15 | -$75.00K derived: sum of 3 quarters · filed 2024-05-15 | $670.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$52.00K derived: sum of 2 quarters · filed 2024-04-01 | $693.00K derived: sum of 3 quarters · filed 2024-04-01 | $688.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $722.00K derived: sum of 2 quarters · filed 2023-11-14 | $717.00K 10-Q · filed 2023-11-14 | $722.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $745.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $740.00K 10-Q · filed 2023-08-14 | $745.00K derived: sum of 3 quarters · filed 2023-08-14 | $732.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$5.00K 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | -$13.00K derived: sum of 3 quarters · filed 2023-05-15 | -$24.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$8.00K derived: sum of 2 quarters · filed 2023-03-31 | -$19.00K derived: sum of 3 quarters · filed 2023-03-31 | -$30.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$24.00K derived: sum of 2 quarters · filed 2022-11-14 | -$35.00K 10-Q · filed 2022-11-14 | -$44.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$22.00K 10-Q · filed 2022-08-15 | -$31.00K derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$11.00K 10-Q · filed 2022-05-13 | -$20.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $27.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $36.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |